NCT02751996 - A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions

Hepatitis BHepatitis, Viral

Interventions

DRUG

SB 9200

DRUG

Placebo

DRUG

Tenofovir

Trial Locations (17)

Spring Bank Pharma Research site, Calgary

Spring Bank Pharma Research site, Vancouver

Spring Bank Pharma Research Site, London

Spring Bank Pharma Research site, Toronto

Spring Bank Pharma Research site, Vaughan

Spring Bank Pharma Research site, Hong Kong

Spring Bank Pharma Research site, Shatin

Spring Pharma Research Site, Chuncheon

Spring Bank Pharma Research site, Yangsan

Spring Bank Pharma Research site, Busan

Spring Bank Pharma Research Site, Daegu

Spring Bank Pharma Research site, Goyang-si

Spring Bank Pharma Research site, Seoul

Spring Bank Pharma Research Site, Chia-Yi City

Spring Bank Pharma Research Site, New Taipei City

Spring Bank Pharma Research Site, Taipei

Spring Bank Pharma Research Site, Taoyuan